How do you pay?

How to pay the least

Ask for the cash price

Otulfi

Otulfi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Otulfi’s cash price, and one or two other pharmacies too.
  2. Otulfi’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameOtulfi
Authorized genericustekinumab-aauz
Regular genericustekinumab-aauz
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Otulfi?
The original
–
–

Brand nameThe maker’s card

KabiCare Copay Program

Savings card from Fresenius Kabi

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Print the card (PDF) 

Or call 1-833-522-4227. See the offer on kabicare.us

In the maker’s words

“If you have commercial or private insurance, you may be eligible for the copay program that lowers your out-of-pocket costs to as little as $0/month for treatment with an annual maximum.”

From the maker’s offer on kabicare.us, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Otulfi itself, from the same company, sold without the brand name, and usually for less. For now Otulfi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Otulfi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

OTULFI is a human interleukin-12 and -23 antagonist indicated for the treatment of:

Adult patients with:

  • moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy.
  • active psoriatic arthritis (PsA).
  • moderately to severely active Crohn's disease (CD).
  • moderately to severely active ulcerative colitis.

Pediatric patients 6 years and older with:

  • moderate to severe plaque psoriasis (PsO), who are candidates for phototherapy or systemic therapy.
  • active psoriatic arthritis (PsA).

Source: the FDA label for Otulfi (Fresenius Kabi USA, LLC), February 16, 2026. Full label on DailyMed 

Good to know